000 01642 a2200457 4500
005 20250513045119.0
264 0 _c19950227
008 199502s 0 0 eng d
022 _a8756-3320
024 7 _a10.1089/jop.1994.10.561
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRahimy, M H
245 0 0 _aEffects of an intravitreal daunomycin implant on experimental proliferative vitreoretinopathy: simultaneous pharmacokinetic and pharmacodynamic evaluations.
_h[electronic resource]
260 _bJournal of ocular pharmacology
_c1994
300 _a561-70 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDaunorubicin
_xpharmacokinetics
650 0 4 _aDisease Models, Animal
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Carriers
650 0 4 _aDrug Implants
650 0 4 _aFluorophotometry
650 0 4 _aPigment Epithelium of Eye
_xgrowth & development
650 0 4 _aRabbits
650 0 4 _aRandom Allocation
650 0 4 _aRetinal Detachment
_xpathology
650 0 4 _aTime Factors
650 0 4 _aVitreoretinopathy, Proliferative
_xdrug therapy
650 0 4 _aVitreous Body
_xmetabolism
700 1 _aPeyman, G A
700 1 _aFernandes, M L
700 1 _ael-Sayed, S H
700 1 _aLuo, Q
700 1 _aBorhani, H
773 0 _tJournal of ocular pharmacology
_gvol. 10
_gno. 3
_gp. 561-70
856 4 0 _uhttps://doi.org/10.1089/jop.1994.10.561
_zAvailable from publisher's website
999 _c7836203
_d7836203